EYPT | EyePointNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$0.40
+$0.03 (+6.70%)

EyePoint (EYPT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.

The 50 SMA has sat below the 200 on the daily since May 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour. On the weekly a death cross is projected within 10 bars.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $0.40 vs 50 $3.02 / 200 $10.83
Projection
No cross projected
Test
No active test
Last cross
Death cross 14 May 2026 ยท projected 10 bars out ยท tested 1 bar

Weekly as of 30 Oct 16:00 ET

Price
below both $0.35 vs 50 $11.90 / 200 $10.82
Projection
Death cross projected in 5 bars
Test
No active test
Last cross
Golden cross week of 5 Jan 2026 ยท projected 24 bars out

4-hour as of 3 Nov 16:00 ET

Price
below both $0.40 vs 50 $1.86 / 200 $7.70
Projection
No cross projected
Test
No active test
Last cross
Death cross 3 Aug 2026 bar 2 ยท projected 26 bars out ยท tested 1 bar

Cross history

33
crosses on record since 2019
17 golden16 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
3 Aug 2026Death4-hour26 bars out1 bar cross test
21 Jul 2026Golden4-hour21 bars outNot tested
14 May 2026Death moderatedaily10 bars out1 bar cross test
30 Mar 2026Death4-hour25 bars outNot tested
25 Feb 2026Golden4-hour30 bars outNot tested

About EYPT

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$12.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.